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To the Editor:
Rubio et al. (1) reported in Cancer Research that adipose tissue–
derived stem cells acquired a transformed phenotype after long-
term culture in vitro . This article has been cited together with our
article published in the same issue (2) as evidence for the malignant
transformation potential of stem cells by the news media. Whereas
our study showed the dangers of having a continuous high level of
telomerase activity during long-term in vitro culture of adult stem
cells, the study of Rubio et al. employed what seemed to be ‘‘normal’’
cells. We have previously cultured several strains of normal human
bone marrow–derived mesenchymal stem cells and we have not
observed ‘‘immortalization’’ of the cells (3). Unfortunately, the
authors refer to our cells as another example of the human adipose-
derived MSC, which is not correct. The differences between our
study and the study by Rubio et al., therefore, need clarification
because they may have an important effect on the stem cell field. It
is possible that the donors employed by Rubio et al. were harboring
a disease and the clinical data related to these donors need to
be provided as well as the reason for undergoing the surgical
procedure. Furthermore, growth curves of the individual cell lines
established should be provided and the authors should provide data
showing at which population doubling level the cells entered crisis.
Finally, the high percentage of the transformation events and the
similarity between the cell lines described require proof that the
cells that formed the tumors were the cells present at the beginning
of the culture by using DNA fingerprinting. These issues are
important to resolve because they are important for the stem cell
community as a whole.
Moustapha Kassem
Jorge S. Burns
Department of Endocrinology and Metabolism
Medical Biotechnology Center
Odense University Hospital
Winsløwparken 25.1, Odense C, Denmark
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In Response:
In our previous paper (1), we referred to Serakinci’s work (2) as an
example of human adipose-derived mesenchymal stem cells when
they really worked with bone marrow–derived mesenchymal stem
cells. We apologize for the confusion that this may have produced
among readers.
In response to Dr. Kassem’s comments, we would like to clarify
that our samples of mesenchymal stem cells were always obtained
from appendicitis surgical procedures of patients with no other
diseases. In our article, we commented that mesenchymal stem
cells reached a senescence phase after 2 months in culture,
equivalent to 20 population doublings. After bypassing the
senescence phase, all mesenchymal stem cells continued to grow
until reaching a crisis phase, 8 months (45 population doublings)
after senescence bypass. This growth curve is the rule when
working with mesenchymal stem cells. The growth curve reached a
plateau for f2 weeks during the senescence phase.
Dr. Kassem cautions about the possible existence of contami-
nation (another cell line) of the samples that became transformed.
Because this was a major concern for us, we took some safety
checkpoints. Anytime transformation was confirmed, we recul-
tured an aliquot of the original mesenchymal stem cells, frozen at
the second initial passing. We then maintained these samples
under the culture conditions described in the paper and obtained
the same results: transformation among aliquots of samples that
had already became tumorigenic and death among aliquots of
samples that never did. This fact points to some genetic
susceptibility in the spontaneous transformation of mesenchymal
stem cells. In addition, we transduced mesenchymal stem cells
with retroviral vectors and enhanced green fluorescent protein
expression was maintained both in the pretransformed and in the
posttransformed mesenchymal stem cells. Another important point
was the fact that the same type of malignant transformation was
observed in human as well as in murine adipose-derived
mesenchymal stem cells. Taken together, these data support the
idea that spontaneous transformation of adipose-derived mesen-
chymal stem cells had occurred in vitro . We also think that the
transformation capacity of mesenchymal stem cells is not
universal, but there is a still unknown susceptibility in some, but
not all, mesenchymal stem cell samples. We agree with Dr. Kassem
that this is an exciting field of research, with clear importance
when thinking in the clinical use of in vitro–expanded human
mesenchymal stem cells.
Javier Garcı´a Castro
Daniel Rubio Mun˜oz
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Madrid, Spain
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